🔴 en direct #JSMDM2026
2ème table ronde sur le sujet « Droits et santé sexuels et reproductifs : relever les défis dans des contextes dégradés ».
Avec les interventions de @AckAlice, @ACCourchinoux, @bethAsully et Dr Israa Saleh.
À suivre ici 👇
https://t.co/d8cQy5d8Wb
Guttmacher’s latest global research highlights what’s needed to advance #SRH: prioritize contraceptive innovation, fund cost-effective SRH services and safe abortion care, and adopt person-centered measures that reflect people’s needs and wants.
#GlobalHealth#Research
New Guttmacher data from Adding It Up 2024 shows what it would take to meet SRH needs across 128 LMICs: 928M women want to avoid pregnancy, 214M aren’t using modern contraception, and every $1 invested saves $2.48 in health care costs. Learn more: https://t.co/fkVTWdRUwr
Two new papers in The Lancet co-authored by Guttmacher experts highlight how innovation & investment in SRHR expands contraceptive choice, advances equity, and saves lives: https://t.co/2FqC7fB8zp
The Trump administration’s foreign aid cuts are devastating global reproductive health & rights. In @MsMagazine, our expert @florianemborel joins @GlobalJusticeC & @P4HR to unpack the damage & what can be done to protect people & health systems worldwide. https://t.co/iWBqdgZnfb
New analysis: #Mifepristone is safe, effective and widely accepted in the US, but remains a prime target of the anti-abortion movement. Guttmacher experts examine escalating attacks on mife, including the current politically motivated review at the FDA. https://t.co/VTQcKNzHOH
9 CDC Directors going back to 1977 speak out. What RFK Jr has done to our nation’s public health system "should alarm every American."
It "is unlike anything we have ever seen at the agency, and unlike anything our country has ever experienced." https://t.co/hYWnhYjCDY
Mifepristone is one of two drugs used in the most common medication abortion regimen in the US. It's safe, effective & widely accepted.
Guttmacher scientists are proud to sign onto a letter by @ANSIRH & @UCLAReproPolicy calling on the FDA to protect #MedicationAbortion access.
Are you at #IPC2025? Visit us at booth 23–24 to connect with our experts in sexual and reproductive health and rights (#SRHR), explore our latest publications and join us for two dynamic spotlight sessions this week!
Yesterday at #IPC2025, our research scientists joined colleagues on a panel to discuss how to meet major challenges facing #SRHR, such as anti-rights backlash and mis- & disinformation. They were united in their message: progress demands bold, coordinated & collaborative action.
📣 family planning saves lives- 34,000 lives last year alone.
Voting for the rescissions package is a vote to say those lives don’t matter. It’s a vote to turn your back on the world’s poorest women & deny them basic health care & the chance to build a better future.
Global health journalist @TulipMazumdar recently travelled to Uganda to make a short film for MSI, documenting our programme and the impact of international aid cuts.
She met with women using contraception — and heard what’s at stake when that choice is taken away.
We're heading to #IPC2025 in Brisbane soon!
Attend our spotlight sessions on new measurement methods shaping evidence-based #SRHR solutions, and meet ACORCA—the African Coalition for Research and Communication on Abortion.
📍 Booth # 23–24
🔗 https://t.co/UnBuua9UK4
We are in unparalleled times in the field of SRHR, but having leaders like @Onykepe - with a vision and a power to unite - brings me hope. I cannot express just how thrilled I am to have her leading our team 💕🤩
We're thrilled to announce that Dr. Onikepe Owolabi has been appointed VP for International Research at the Guttmacher Institute.
Dr. Owolabi will lead a globally recognized team of scientists as they conduct critical research to advance SRHR worldwide. https://t.co/QFAXQDLHQE
We are excited to announce another new #SheDecides champion, The Guttmacher Institute.
We welcome the Institute's strong commitment to fight back with facts during times of pushback against abortion rights.
#IWD2025#AbortionRights#ResistTheRollback
Human rights groups brace for the next steps in U.S. policy on abortion. Time's latest piece explores what's been done and what's next, with insights from #SheDecides Champions FIGO, Center for Reproductive Rights
& Guttmacher Institute: https://t.co/gYEpzIJhYQ.
#USPolicy#SRHR
This is what abortions bans do. They deny people access to evidence-based essential health care, like treatment for second trimester miscarriages. This impacts everyone and we shouldn't stand for it. https://t.co/SAwy8bpBAJ
Great piece in The Independent on the devestating - and cruel - harms from the Trump foreign aid freeze, an in particular it's impact on women and girls around the world.
https://t.co/77IvUHXXfP
The Trump admin's stop-work order on US foreign aid is devastating. Our experts predict that 11.7 million women & girls will be denied access to contraceptive care during the 90-day freeze.
More from @guardian: https://t.co/11OzGMixJF
Demand an end to the freeze on US foreign aid that could result in an estimated 4.2 million unintended pregnancies and 8,340 maternal deaths. Resuming work tomorrow would restore access to essential health care for millions.
More in our policy analysis: https://t.co/2GazngH3n5